Biocon Ltd buy melinda
Start price
07.09.17
/
50%
?2.26
Target price
30.11.17
€3.25
Performance (%)
23.78%
End price
30.11.17
€2.80
Summary
This prediction ended on 30.11.17 with a price of €2.80. The BUY prediction by melinda finished with a performance of 23.78%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Biocon Ltd | - | - | - | - |
iShares Core DAX® | -0.621% | 1.080% | 11.291% | 16.439% |
iShares Nasdaq 100 | -4.503% | -5.432% | 22.172% | 39.304% |
iShares Nikkei 225® | -2.562% | -1.617% | 7.262% | 8.383% |
iShares S&P 500 | -1.706% | -1.223% | 22.550% | 40.997% |
Comments by melinda for this prediction
In the thread Biocon Ltd diskutieren
Biotechnologie und Medizintechnik
Biocon sagt die Insuline in Malaysia ein EU - GMP - Konformitätszertifikat erhalten
7. September (Reuters) - Biocon Ltd Biocon Insulin Institutionen in Malaysia erhalten eine EU - GMP - Konformitätsbescheinigung
(Vom Mitglied beendet)